Aemetis Inc (NAS:AMTX)

Q2 2026 Aemetis Inc Earnings Call Transcript

Aug 6, 2026 / 06:00 PM GMT

Release Date Price: $1.63 (+5.16%)

Transcript 10-Q8-K

Key Points

Positve

Aemetis Inc (AMTX) reported strong financial improvements in Q2 2026, with revenue growing 20% year-over-year to $62.7 million, operating income improving by $16.4 million to $5.8 million, and adjusted EBITDA increasing by $15.5 million to $9.7 million.
The company received $17.6 million in net cash proceeds from the sale of Section 45Z credits in July, providing a significant liquidity boost.
Aemetis Inc (AMTX) has seven approved California LCFS pathways for its dairy RNG business with an average carbon intensity score of negative 380, which substantially increases credit generation per MMBTU, and six more pathways are nearing approval.
The Mechanical Vapor Recompression (MVR) project at the California ethanol plant is on track for operation by the end of 2026 and is expected to add approximately $32 million in annual cash flow through reduced natural gas costs and higher credit values.
The India biodiesel business received new allocations from three government-owned oil marketing companies in late July, expected to generate approximately $17 million in revenue, and is also expanding sales to private commercial customers due to rising diesel prices.
The company is actively pursuing a potential public offering of a minority stake in its India subsidiary, Universal Biofuels, subject to market conditions, which could provide additional capital.

Negative

Aemetis Inc (AMTX) ended Q2 2026 with only $1 million in cash, indicating a tight liquidity position despite recent credit sales.
The company's biodiesel revenue in India was down sequentially to $2.5 million in Q2, as the oil marketing companies worked through their tender process, highlighting the start-stop nature of this business.
The Department of Energy has not yet corrected the 45Z emissions rate for RNG, which is currently generating significantly less revenue ($15.20 per MMBTU) than the company believes is warranted, creating uncertainty and delaying potential revenue uplifts.
The company faces uncertainty regarding the timing and amount of potential 45Z catch-up payments, with the range of potential net cash improvement being wide ($6 million to $24 million) and dependent on regulatory decisions.
The India IPO process for Universal Biofuels has been delayed due to unfavorable market conditions, including a downturn in the Indian stock market and a bottleneck in the IPO pipeline, pushing the timeline potentially into 2027.
Aemetis Inc (AMTX) carries a significant amount of debt with its private credit provider, Third Eye Capital, and while some is at a low interest rate, the company's ability to refinance the balance at lower rates depends on future large cash events like 45Z catch-ups.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AMTX.OQ - Aemetis Inc
Q2 2026 Aemetis Inc Earnings Call
Aug 06, 2026 / 06:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and welcome to the A-Metus Second Quarter 2026 Earnings Conference Call.

Joining us today are Eric McAfee, Chairman and Chief Executive Officer Todd Walz, Chief Financial Officer and Andy Foster, President of A-Metus Advanced Fuels.

I will now turn the call over to Mr. Todd Walz.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you and welcome, everyone. Before we begin, I'd like to remind you that during the call, we'll make forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1,995. These statements involve risk and

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.